Status:
COMPLETED
Efficacy of Intensive Cholecalciferol Monitoring and Supplementation on Serum vitD Levels in Pediatric Patients With CF
Lead Sponsor:
Hospital Infantil de Mexico Federico Gomez
Conditions:
Vitamin D Deficiency
Cystic Fibrosis
Eligibility:
All Genders
5-18 years
Phase:
PHASE4
Brief Summary
Cystic fibrosis (CF) is an autosomal recessive disease caused by alterations in the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) gene, characterized by multisystemic alterations, mainly ...
Detailed Description
Randomized double-blind clinical trial in patients aged 5 to 18 years attending the CF Comprehensive Care clinic in Mexico City. The intervention group will receive an intensification of vitamin D sup...
Eligibility Criteria
Inclusion
- Cystic Fibrosis
Exclusion
- Another chronic disease (HIV, cancer, renal failure)
- 25-OH-VitD levels \< 10 ng/ml or \> 30 ng/ml
Key Trial Info
Start Date :
June 22 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 30 2025
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT05276960
Start Date
June 22 2022
End Date
January 30 2025
Last Update
April 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Infantil de México Federico Gómez
Mexico City, Mexico City, Mexico, 06700